Wang Q, Dong H. Complete hydatidiform mole in a 52-year-old postmenopausal woman: A case report and literature review.
Case Rep Womens Health 2021;
31:e00338. [PMID:
34258236 PMCID:
PMC8255813 DOI:
10.1016/j.crwh.2021.e00338]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2021] [Revised: 06/12/2021] [Accepted: 06/16/2021] [Indexed: 11/25/2022] Open
Abstract
Benign gestational trophoblastic disease generally occurs in women of reproductive age and is extremely rare in postmenopausal women. Here, the authors describe a case of complete hydatidiform mole in a 52-year-old postmenopausal woman with a history of lower abdominal bloating and vaginal bleeding. The paper summarizes the clinical manifestations, physiopathology, diagnosis, and treatment options for gestational trophoblastic disease in postmenopausal women. This study highlights that gestational trophoblastic disease can occur in postmenopausal women and that it is important to include it in the differential diagnosis of postmenopausal bleeding, to prevent delay in treatment.
Hydatidiform mole (HM) is extremely rare in postmenopausal women.
Patients with hydatidiform mole generally present with vaginal bleeding.
Prophylactic chemotherapy can prevent distant metastasis of hydatidiform mole.
Follow-up monitoring of serum β-HCG levels is vital after therapy.
Collapse